ConductScience.org, home

Paper39728367

New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions.

Niño-Vega GA and 2 others. J Fungi (Basel), 2024. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions. Papers, record 39728367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39728367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions.
PubMed
Journal
J Fungi (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
4.75, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Niño-Vega GAGustavo Ahttps://orcid.org/0000-0003-3760-5620
2Padró-Villegas LLeonardohttps://orcid.org/0009-0001-5913-3401
3López-Romero EEverardo

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References107

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128597822Fungi that Infect Humans.Microbiol Spectr2017https://conductscience.org/library/papers/28597822PubMed
226160833Development and Application of a High-Throughput Screening Method to Evaluate Antifungal Activity against Trichophyton tonsurans.J Biomol Screen2015https://conductscience.org/library/papers/26160833PubMed
332849347Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions.Front Microbiol2020https://conductscience.org/library/papers/32849347PubMed
429208749Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation.mBio2017https://conductscience.org/library/papers/29208749PubMed
539195465Recent Advances in Marine-Derived Compounds as Potent Antibacterial and Antifungal Agents: A Comprehensive Review.Mar Drugs2024https://conductscience.org/library/papers/39195465PubMed
638807795Fosmanogepix: The Novel Anti-Fungal Agent's Comprehensive Review of in Vitro, in Vivo, and Current Insights From Advancing Clinical Trials.Cureus2024https://conductscience.org/library/papers/38807795PubMed
729555634Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29555634PubMed
835069463Antibiofilm Activities of Biogenic Silver Nanoparticles Against Candida albicans.Front Microbiol2021https://conductscience.org/library/papers/35069463PubMed
98457977Compounds active against cell walls of medically important fungi.Clin Microbiol Rev1993https://conductscience.org/library/papers/8457977PubMed
1031611349Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31611349PubMed
1128069658SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28069658PubMed
1222271309Molecular basis for fungicidal action of neothyonidioside, a triterpene glycoside from the sea cucumber, Australostichopus mollis.Mol Biosyst2012https://conductscience.org/library/papers/22271309PubMed
1336257999Antifungal activity and genomic characterization of the biocontrol agent Bacillus velezensis CMRP 4489.Sci Rep2022https://conductscience.org/library/papers/36257999PubMed
1434209118Niclosamide Is Active In Vitro against Mycetoma Pathogens.Molecules2021https://conductscience.org/library/papers/34209118PubMed
1537894800Design, Synthesis, and Biological Evaluation of N'-Phenylhydrazides as Potential Antifungal Agents.Int J Mol Sci2023https://conductscience.org/library/papers/37894800PubMed
1632722455Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy.Antibiotics (Basel)2020https://conductscience.org/library/papers/32722455PubMed
1731818813Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/31818813PubMed
1828158577In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.J Antimicrob Chemother2017https://conductscience.org/library/papers/28158577PubMed
1934001513In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis.Antimicrob Agents Chemother2021https://conductscience.org/library/papers/34001513PubMed
2030976107Applications of machine learning in drug discovery and development.Nat Rev Drug Discov2019https://conductscience.org/library/papers/30976107PubMed

See all 107 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42930693Advances in Azole Antifungal Agents: From Structural Foundations to Resistance Challenges.J Fungi (Basel)2026https://conductscience.org/library/papers/42930693PubMed
42733675Pathogenesis and Triazole Resistance in Aspergillus fumigatus: A Narrative Review Across the Host Immune Spectrum and One Health Context.Infect Drug Resist2026https://conductscience.org/library/papers/42733675PubMed
42653695Pyrrolidine-Based Antifungal Agents Against Candida Species: A Systematic Review of Structure-Activity Relationships and Mechanistic Insights from Experimental Studies.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653695PubMed
42346544Heat Shock Proteins in Medically Relevant Fungal Pathogens: From Molecular Chaperones to Virulence Factors and Therapeutic Targets.J Fungi (Basel)2026https://conductscience.org/library/papers/42346544PubMed
41893109In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous Species Xylaria karsticola NBIMCC 9097, with Insights into Its Antimicrobial Potential.J Fungi (Basel)2026https://conductscience.org/library/papers/41893109PubMed
41835000Structural barriers to antifungal drug development.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/41835000PubMed
41590420From the Ground to the Clinic: The Evolution and Adaptation of Fungi.J Fungi (Basel)2025https://conductscience.org/library/papers/41590420PubMed
41545875Antifungal activity of oily core PEGylated PLGA nanocapsules loaded with Penicillium oxalicum fungal extract: in vitro, in vivo, and in silico study.Microb Cell Fact2026https://conductscience.org/library/papers/41545875PubMed
41149925Candida krusei Empyema: A Lung Transplant Case and Systematic Review of the Literature.J Fungi (Basel)2025https://conductscience.org/library/papers/41149925PubMed
40957969Fungal infections in focus: accelerating non-invasive imaging from preclinical insights to clinical breakthroughs.Npj Imaging2025https://conductscience.org/library/papers/40957969PubMed
40869230Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin.Int J Mol Sci2025https://conductscience.org/library/papers/40869230PubMed
40261080In vitro activity of SF001: a next-generation polyene versus amphotericin B.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40261080PubMed
40076689Special Issue "Antifungal Drug Discovery: Progresses, Challenges, Opportunities".Int J Mol Sci2025https://conductscience.org/library/papers/40076689PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39728367

GET https://conductscience.org/api/papers/v1/39728367/references?page=2